Skip to main content
Fluidics for Preclinical, Life Science Research, and Clinical Applications Market by Product, End-user, and Geography - Forecast and Analysis 2021-2025

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market by Product, End-user, and Geography - Forecast and Analysis 2021-2025

Published: Nov 2021 120 Pages SKU: IRTNTR44975

Market Overview at a Glance

$10.38 B
Market Opportunity
19.1%
CAGR
YoY growth 2020-2021(%)

The fluidics for preclinical, life science research, and clinical applications market share is expected to increase by USD 10.37 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 19.1%.

This fluidics for preclinical, life science research, and clinical applications market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers fluidics for preclinical, life science research, and clinical applications market segmentation by product (software and accessories and precision syringe pumps), end-user (industrial laboratories and CROs and academic, and government research laboratories), and geography (North America, Europe, Asia, and ROW). The fluidics for preclinical, life science research, and clinical applications market report also offers information on severl market vendors, including Advanced Microfluidics SA, BiosebLab, CETONI GmbH, Chemyx Inc., Halma Plc, Harvard Bioscience Inc., New Era Pump Systems Inc., Spetec GmbH, Stoelting Co., and World Precision Instruments among others.

What will the Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Size be During the Forecast Period?

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market Size

Download Report Sample to Unlock the Fluidics for Preclinical, Life Science Research, and Clinical Applications Market Size for the Forecast Period and Other Important Statistics

 

Fluidics For Preclinical, Life Science Research, And Clinical Applications Market: Key Drivers, Trends, and Challenges

The rise in prevalence of chronic diseases driving cellular research is notably driving the fluidics for preclinical, life science research, and clinical applications market growth, although factors such as limitations of syringe pumps may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the fluidics for preclinical, life science research, and clinical applications industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Driver

The rise in prevalence of chronic diseases driving cellular research is one of the key factors driving the growth of the global fluidics for preclinical, life science research, and clinical applications market. The growing prevalence of chronic diseases, such as cancer and cardiovascular diseases, globally has increased the demand for cellular research on these diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), during 2010-2020, the number of new cancer cases in the US increased by around 24% in men (more than 1 million cases per year) and by 21% in women (more than 900,000 cases per year). Moreover, the demand for microfluidics-based technology is also increasing in cancer research. For instance, in February 2019, researchers developed a microfluidic device that can isolate individual cancer cells from patients’ blood samples. The device is expected to enable rapid and low-cost liquid biopsies in the future, help detect cancer, and develop targeted treatment plans. The growth in microfluidic research on chronic diseases, such as cancer, is likely to augment the demand for microfluidic syringe pumps, which will drive the growth of the market during the forecast period.

Key Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Trend

Adoption of various business strategies will fuel the global fluidics for preclinical, life science research, and clinical applications market growth. The increasing number of partnerships and collaborations are likely to drive the growth of the global fluidics market for preclinical, life sciences research, and clinical application during the forecast period. Vendors are opting for diverse business strategies, such as partnerships and collaborations with end-users and universities, upgrading their product portfolios, which is expected to drive the growth of the global fluidics market for preclinical, life sciences research, and clinical application market during the forecast period. Moreover, vendors are participating in various trade shows and conferences to attract consumers and promote their products. Participation in such trade shows and conferences helps vendors form strong sales channels with end-users and boost their market presence. Such business strategies adopted by key vendors in the market will drive the growth of the market during the forecast period.

Key Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Challenge

Limitations of syringe pumps are the major challenge for the global fluidics for preclinical, life science research, and clinical applications market growth. Syringe pumps are widely used in life science and preclinical research, as they are easy to use and enable a fast setup of experiments. However, they have certain limitations, which hamper their adoption in research. Moreover, Syringe pumps are used in research for microfluidic applications. When changing the flow rate using a syringe pump within a microfluidic system, the settling time taken to reach 95% of the desired flow rate can range between milliseconds to several hours, as microfluidics often deals with high fluidic capacitance and small flow rates. The pressure in the fluidics system increases when the motor of the syringe pump pushes the syringe piston. The pressure required to reach the desired flow rate increases linearly with the fluidic resistance of the chip and the settled flow rate. Generally, this pressure increase should be reached instantaneously. However, fluidic systems have compliance as they deform with pressure. When the system deforms, it slows down the pressure increase, which further retards the time taken to reach the right flow rate in the chip.

This fluidics for preclinical, life science research, and clinical applications market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

The global fluidics for preclinical, life science research, and clinical applications market is a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the fluidics for preclinical, life science research, and clinical applications market during the forecast period.

Who are the Major Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Advanced Microfluidics SA
  • BiosebLab
  • CETONI GmbH
  • Chemyx Inc.
  • Halma Plc
  • Harvard Bioscience Inc.
  • New Era Pump Systems Inc.
  • Spetec GmbH
  • Stoelting Co.
  • World Precision Instruments

 

This statistical study of the fluidics for preclinical, life science research, and clinical applications market encompasses successful business strategies deployed by the key vendors. The fluidics for preclinical, life science research, and clinical applications market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Advanced Microfluidics SA - The company offers fluidics for preclinical, life science research, and clinical applications such as LSPone laboratory syringe pump, OEM RVM microfluidic electric rotary valve among others.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The fluidics for preclinical, life science research, and clinical applications market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the fluidics for preclinical, life science research, and clinical applications market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the global life sciences tools and services market includes the following core components:

  • Inputs
  • Inbound logistics
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Service
  • Support activities
  • Innovation

The report has further elucidated other innovative approaches being followed by service providers to ensure a sustainable market presence.

 

Which are the Key Regions for Fluidics For Preclinical, Life Science Research, And Clinical Applications Market?

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

44% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for fluidics for preclinical, life science research, and clinical applications market in North America. Market growth in this region will be slower than the growth of the market in regions.

The rise in prevalence of chronic diseases driving cellular research will facilitate the fluidics for preclinical, life science research, and clinical applications market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The fluidics for preclinical, life science research, and clinical applications market in North America witnessed strong growth in the 2020-2021 period, owing to the outbreak of COVID-19. The rising number of COVID-19 cases resulted in significant pressure on healthcare facilities in this region. Laboratories increased their testing capacities to address the increasing demand for COVID-19 testing. These COVID-19 tests are being made compulsory for travel both within countries in North America as well as for traveling to other regions. Also, the number of clinical research activities for COVId-19 vaccines has increased during this COVID-19 period in 2020 and the first half of 2021 due to the rapid spread of COVID-19 cases. This, in turn, is expected to facilitate the growth of the fluidics for preclinical, life science research, and clinical applications market in the region during the forecast period.

What are the Revenue-generating Product Segments in the Fluidics For Preclinical, Life Science Research, And Clinical Applications Market?

Fluidics for Preclinical, Life Science Research, and Clinical Applications Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The fluidics for preclinical, life science research, and clinical applications market share growth by the Software and accessories segment will be significant during the forecast period. This segment includes software tools and accessories that are integrated into syringe pumps. A variety of accessories are available for the syringe pump product line in the market. As the use of accessories aid in the functioning of syringe pumps, it will drive the growth of the accessories segment during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the fluidics for preclinical, life science research, and clinical applications market size and actionable market insights on post COVID-19 impact on each segment.

 

Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 19.1%

Market growth 2021-2025

$ 10.37 billion

Market structure

Fragmented

YoY growth (%)

13.00

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 44%

Key consumer countries

US, China, Germany, Canada, and the UK

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Advanced Microfluidics SA, BiosebLab, CETONI GmbH, Chemyx Inc., Halma Plc, Harvard Bioscience Inc., New Era Pump Systems Inc., Spetec GmbH, Stoelting Co., and World Precision Instruments

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Fluidics For Preclinical, Life Science Research, And Clinical Applications Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive fluidics for preclinical, life science research, and clinical applications market growth during the next five years
  • Precise estimation of the fluidics for preclinical, life science research, and clinical applications market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the fluidics for preclinical, life science research, and clinical applications industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of fluidics for preclinical, life science research, and clinical applications market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Fluidics for Preclinical, Life Science Research, and Clinical Applications market growth will increase by 10375.97 million during 2021-2025.

The Fluidics for Preclinical, Life Science Research, and Clinical Applications market is expected to grow at a CAGR of 19.1% during 2021-2025.

Fluidics for Preclinical, Life Science Research, and Clinical Applications market is segmented by Product( Software and accessories, Precision syringe pumps) End user( Industrial laboratories and CROs, Academic and government research laboratories) Geographic( North America, Europe, Asia, ROW, North America)

Advanced Microfluidics SA, BiosebLab, CETONI GmbH, Chemyx Inc., Halma Plc, Harvard Bioscience Inc., New Era Pump Systems Inc., Spetec GmbH, Stoelting Co., World Precision Instruments are a few of the key vendors in the Fluidics for Preclinical, Life Science Research, and Clinical Applications market.

North America will register the highest growth rate of 43.71% among the other regions. Therefore, the Fluidics for Preclinical, Life Science Research, and Clinical Applications market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, China, Germany, Canada, UK

  • Rise in prevalence of chronic diseases driving cellular researchThe growing prevalence of chronic diseases is the driving factor this market.
  • such as cancer and cardiovascular diseases is the driving factor this market.
  • globally has increased the demand for cellular research on these diseases. For instance is the driving factor this market.
  • according to the Centers for Disease Control and Prevention (CDC) is the driving factor this market.
  • during 2010-2020 is the driving factor this market.
  • the number of new cancer cases in the US increased by around 24% in men (more than 1 million cases per year) and by 21% in women (more than 900 is the driving factor this market.
  • 000 cases per year).The high prevalence of chronic diseases has driven research activities in this field. It has also increased the need for new breakthrough technologies for their treatment. This is the driving factor this market.
  • in turn is the driving factor this market.
  • drives the demand for fluidic technologies and products is the driving factor this market.
  • such as precision syringe pumps is the driving factor this market.
  • as they are used in several cellular and analytical techniques is the driving factor this market.
  • such as chromatography is the driving factor this market.
  • microfluidics is the driving factor this market.
  • and cellular studies. Moreover is the driving factor this market.
  • disorders associated with changing lifestyles is the driving factor this market.
  • such as diabetes and obesity is the driving factor this market.
  • and respiratory disorders due to increasing habits of smoking are also on the rise. Hence is the driving factor this market.
  • the rising prevalence of various chronic diseases increases the demand for research in various fields of the pharmaceutical sector is the driving factor this market.
  • which is the driving factor this market.
  • in turn is the driving factor this market.
  • is expected to drive market growth during the forecast period. The growth in drug discovery and preclinical research for the development of treatment for chronic diseases will drive the demand for fluidic products used in these activities.The demand for microfluidics-based technology is also increasing in cancer research. For instance is the driving factor this market.
  • in February 2019 is the driving factor this market.
  • researchers developed a microfluidic device that can isolate individual cancer cells from patients blood samples. The device is expected to enable rapid and low-cost liquid biopsies in the future is the driving factor this market.
  • help detect cancer is the driving factor this market.
  • and develop targeted treatment plans. The growth in microfluidic research on chronic diseases is the driving factor this market.
  • such as cancer is the driving factor this market.
  • is likely to augment the demand for microfluidic syringes pumps is the driving factor this market.
  • which will drive the growth of the market during the forecast period. is the driving factor this market.

The Fluidics for Preclinical, Life Science Research, and Clinical Applications market vendors should focus on grabbing business opportunities from the Software and accessories segment as it accounted for the largest market share in the base year.